205 related articles for article (PubMed ID: 10334498)
1. Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
Shi X; Yin R; Dow-Edwards D
Eur J Pharmacol; 1999 Apr; 370(3):241-9. PubMed ID: 10334498
[TBL] [Abstract][Full Text] [Related]
2. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
[TBL] [Abstract][Full Text] [Related]
4. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
Shapiro LA; Offord SJ; Ordway GA
Brain Res; 1995 Apr; 677(2):250-6. PubMed ID: 7552250
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
Alburges ME; Narang N; Wamsley JK
Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptics and dopamine transporters.
Reader TA; Ase AR; Huang N; Hébert C; van Gelder NM
Neurochem Res; 1998 Jan; 23(1):73-80. PubMed ID: 9482270
[TBL] [Abstract][Full Text] [Related]
10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
11. Regional brain changes in [3H]SCH 23390 binding to dopamine D1, receptors after long-term haloperidol treatment: lack of correspondence with the development of vacuous chewing movements.
Sasaki T; Kennedy JL; Nobrega JN
Behav Brain Res; 1998 Feb; 90(2):125-32. PubMed ID: 9521545
[TBL] [Abstract][Full Text] [Related]
12. Behavioral responses to dopamine agonists in adult rats exposed to cocaine during the preweaning period.
Dow-Edwards DL; Busidan Y
Pharmacol Biochem Behav; 2001 Sep; 70(1):23-30. PubMed ID: 11566139
[TBL] [Abstract][Full Text] [Related]
13. Influence of cocaine administration patterns on dopamine receptor regulation.
Puig S; Marie N; Benturquia N; Noble F
Psychopharmacology (Berl); 2014 Aug; 231(16):3131-7. PubMed ID: 24557089
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
[TBL] [Abstract][Full Text] [Related]
15. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
Johansson B; Georgiev V; Fredholm BB
Neuroscience; 1997 Oct; 80(4):1187-207. PubMed ID: 9284070
[TBL] [Abstract][Full Text] [Related]
16. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
17. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
18. Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms.
Masserano JM; Baker I; Natsukari N; Wyatt RJ
Neurosci Lett; 1996 Oct; 217(2-3):73-6. PubMed ID: 8916075
[TBL] [Abstract][Full Text] [Related]
19. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
Filip M; Przegaliński E
Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
Salmi P; Malmgren K; Svensson TH; Ahlenius S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
